Clinical trial
Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV…
NCT00245154 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00245154 |
|---|---|
| Title | Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer |
| Official title | A Phase II/III Double Blind Randomized Trial of AZD2171 Versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Other |
| Interventions | carboplatin, cediranib maleate, paclitaxel, placebo |
| Enrollment | 296 |
| Start date | Nov 3, 2005 |
| Primary completion | Jul 4, 2008 |
| Completion | Jan 10, 2013 |
| First posted | Oct 27, 2005 |
| Last update posted | Aug 4, 2023 |
| Countries | Argentina, Australia, Brazil, Canada, Romania, Singapore |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: